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Abstract Potentilla anserina L. (Rosaceae) is known for
its beneficial effects of prevention of pre-menstrual syn-
drome (PMS). For this reason P. anserina is processed into
many food supplements and pharmaceutical preparations.
Here we analyzed hydroalcoholic reference extracts and
compared them with various extracts of different phar-
macies using an integrative metabolomics platform com-
prising GC-MS and LC-MS analysis and software
toolboxes for data alignment (MetMAX Beta 1.0) and
multivariate statistical analysis (COVAIN 1.0). Multivari-
ate statistics of the integrated GC-MS and LC-MS data
showed strong differences between the different plant
extract formulations. Different groups of compounds such
as chlorogenic acid, kaempferol 3-O-rutinoside, acacetin
7-O-rutinoside, and genistein were reported for the first
time in this species. The typical fragmentation pathway of
the isoflavone genistein confirmed the identification of this
active compound that was present with different abun-
dances in all the extracts analyzed. As a result we have
revealed that different extraction procedures from different
vendors produce different chemical compositions, e.g.
different genistein concentrations. Consequently, the
treatment may have different effects. The integrative
metabolomics platform provides the highest resolution of
the phytochemical composition and a mean to define subtle
differences in plant extract formulations.
Keywords Medicinal plants  Metabolomics  GC-MS 
LC-MS  Flavonoids  Genistein  Mass accuracy precursor
alignment (MAPA)
1 Introduction
Potentilla anserina L. (silverweed) belongs to the family of
Rosaceae and its extracts have been used for a long time in
traditional medicine. The gynecological indication for
P. anserina is based on pharmacological studies showing
that the herb increases the tonus of the isolated uterus in
various animal species (Schulz et al. 1998). Additionally,
extracts of the aerial and/or underground parts have been
applied in traditional medicine for the treatment of
inflammations, wounds, certain forms of cancer, infections
due to bacteria, fungi and viruses, diarrhoea, diabetes
mellitus and other ailments (Bundesgesundheitsamt 1985,
1990). Tomczyk and Latte´ report that P. anserina (aerial
parts or the whole plant) and other Potentilla species are
generally used to prepare homeopathic medications
(Tomczyk and Latte´ 2009) according to homeopathic
pharmacopoeias like Homeopathic Pharmacopoeia of the
United States (HPUS) and German Homeopathic Pharma-
copoeia (HAB) (Hiller 1994). For this reason P. anserina is
processed into many food supplements and pharmaceutical
preparations such as teas, tinctures, capsules, tablets, and
juice and is consumed by women in order to prevent the
symptoms of pre-menstrual syndrome (PMS).
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Despite all these positive effects, so far only limited
analytical information of the chemical composition on
P. anserina is available (Swiezewska and Chojnacki 1989;
Kombal and Glasl 1995; Schimmer and Lindenbaum
1995; Tomczyk et al. 2010; Xu et al. 2010). In particular
mass spectrometric data of the chemical composition of
P. anserina are still lacking. These could however be
helpful for the evaluation of physiological properties of
individual plant secondary metabolites and for stability
studies of pharmaceutical preparations. HPLC coupled to
mass spectrometry (LC-MS) proved to be a very useful tool
and is largely applied to the characterization of plant sec-
ondary metabolites. Gas chromatography coupled to mass
spectrometry (GC-MS) provides complementary data to
LC-MS analysis comprising small polar chemicals such as
organic acids, sugars, amino acids, sugar alcohols and
many more (Scherling et al. 2010; Weckwerth 2010). The
aim of the present work is to characterize the phytochem-
ical profile of hydroalcoholic extracts of P. anserina and its
commercial products prepared by different pharmacies
using a comprehensive metabolomics platform integrating
GC-MS, LC-MS and multivariate statistics (Fig. 1).
2 Materials and methods
2.1 Chemicals
Chloroform, ethanol (absolute), methanol, n-butanol, petro-
leum ether (HPLC grade), were purchased from Sigma-
Aldrich (Vienna, Austria) in Chromasolv grade as well as
pyridine over molecular sieve (GC-grade). Acetonitrile
(HPLC grade) and formic acid were obtained from Merck
(Darmstadt, Germany). Chlorogenic acid was purchased from
Roth (Graz, Austria), genistein, quercetin-3-O-glucoside and
D-sorbitol, b-alanine, arabinose, asparagine, citric acid,
D(-)quinic acid, fructose, glucose, glyceric acid, glycerol,
glycine, L-alanine, L-aspartic acid, L-leucine, L-serine, L-thre-
onine, malic acid, mannitol, myo-inositol, phenylalanine,
pinitol, proline, sucrose, trehalose, valine and, xylose were
purchased from Sigma-Aldrich (Vienna, Austria), kaempfer-
ol-3-O-glucoside was obtained from Extrasynthese (Genay,
France). Myricetin-3-O-rhamnoside and quercetin-3-O-glu-
curonide were isolated by size exclusion chromatography and
semipreparative HPLC with UV detection from the hydroal-
coholic extract of P. anserina and their structures were
characterized by 1D and 2D nuclear magnetic resonance
(NMR). For derivatization methoxyamine hydrochloride and
N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) were
purchased from Sigma-Aldrich (Vienna, Austria), as well as
retention index marker alkanes (all even C10–C40). HPLC
grade water (18.2 mX) wE¨as prepared using a Millipore Milli-
Q purification system (Millipore Corp., Bedford, MA, USA).
2.2 Plant material
Potenilla anserina air-dried plant parts were purchased
from Minardi s.r.l. (Bagnacavallo, Ra, Italy). 500 g of
whole plant parts were extracted with petroleum ether three
times. After filtration the raw material was extracted three
times with chloroform and finally with 70 % EtOH fol-
lowing the same procedure performed with petroleum
ether. The collected alcohol-aqueous extract (Panserin-
aUniSa) was dried under vacuum.
Fig. 1 Metabolomics platform for the characterization of medicinal plants integrating GC-MS, LC-MS, alignment tools and statistical analysis
using COVAIN (Sun and Weckwerth 2012)
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A second extract (PanserinaUniVie) was prepared
using a grinding mill system MM400 from Retsch (Haan,
Germany). 250 mg of ground plant material was extracted
with 25 mL of a solution of methanol/chloroform/water
(2.5:1:0.5, v:v:v) (Weckwerth et al. 2004) and then vortexed
for 10 min followed by 8 min incubation. The sample was
then centrifuged for 4 min at 3,4009g and the supernatant
was separated from the pellet. 5 mL of distilled water were
added to the supernatant, followed by 10 s shaking on a
vortex and 2 min centrifugation at 3,4009g. The alcoholic-
aqueous phase was dried under vacuum.
Five mother tinctures were acquired from five drug-
stores (# 1, 2, 3, 4 and 5) in Vienna. For each of them 1 mL
was dried under vacuum.
All samples were analyzed by gas chromatography and
liquid chromatography coupled to mass spectrometry. For
data analysis (see below) all sample injections were nor-
malized against corresponding extract dry weights.
2.3 Extract derivatization and GC-MS analysis
The protocol for GC-MS analysis was performed according
to Weckwerth et al. (2004) with slight changes. Before
derivatization 25 lL of 13C-D-sorbitol (0.02 lg lL-1)
were added to all samples as internal standard. Samples
were derivatized in two steps. First 20 lL methoxyamin-
ation mixture (40 mg mL-1 methoxyamine hydrochloride
in dry pyridine) were added and incubated for 90 min at
30 C in a thermo shaker. Then 80 lL of N-methyl-N-tri-
methylsilyltrifluoroacetamide (MSTFA) silylation mixture
including retention index marker were added (30 lL of
alkane mixture (even-numbered C10-C40-alkanes, each
50 mg L-1) and incubated for 30 min at 37 C.
Derivatized samples were centrifuged and 50 lL of
supernatant was transferred to GC-vials with micro inserts
and closed with crimp caps.
GC-MS analyses were performed on a ThermoFisher
Trace gas chromatograph coupled to a Triple Quadrupole
mass analyzer (Thermo Scientific TSQ Quantum GCTM,
Bremen, Germany). 1 lL of derivatized sample was
injected at a constant temperature of 230 C in splitless
mode with a deactivated Siltek liner (Restek). Each sample
was measured three times with the same conditions to get
technical replicates.
GC separation was performed on a HP-5MS capillary
column (30 m 9 0.25 mm 9 0.25 lm) (Agilent Technol-
ogies, Santa Clara, CA), at a constant flow 1 mL min-1
helium. Initial oven temperature was set to 70 C and hold
for 1 min, followed by a ramp to 76 C at 1 C min-1 and
a second ramp at 6 C min-1 to 350 C hold for 1 min.
Transfer line temperature was set to 340 C and post run
temperature to 325 C for 10 min.
Table 1 Compounds occurring in P. anserina hydroalcoholic
extracts measured by GC/EI(TSQ)MS
Compounds Rt (min) Fragments
m/z
1. Glycolic acid (2TMS) 9.50 147
2. Alanine (2TMS)a 10.28 116
3. Unknown 1 11.36 133
4. Unknown 2 12.59 281
5. Valine (2TMS)a 13.53 144
6. Leucine (2TMS)a 15.03 158
7. Glycerol (3TMS)a 15.24 205
8. Proline (2TMS)a 15.59 142
9. Glycine (3TMS)a 15.81 174
10. Succinic acid (2TMS) 16.06 247
11. Glyceric acid (3TMS)a 16.60 189
12. Serine (3TMS)a 17.30 204
13. Threonine (3TMS)a 17.91 218
14. Malic acid (3TMS)a 20.18 233
15. Pyroglutamic acid (2TMS) 20.57 156
16. Threitol or erythritol (4TMS) 20.67 156
17. Aspartic acid (3TMS)a 20.73 232
18. 4-amino butyric acid (3TMS) 20.79 174
19. Unknown 3 21.73 292
20. Unknown 4 22.13 307
21. Phenylalanine (2TMS)a 22.67 192
22. Asparagine (3TMS)a 23.61 188
23. Arabinose (1MeOx) (4TMS)a 23.76 103
24. Xylose (1MeOx) (4TMS)a 24.05 217
25. Xylitol or ribitol (5TMS) 24.80 217
26. 2-desoxy-pentos-3ylose (2MeOx)(2TMS) 25.30 231
27. Unknown 5 25.79 257
28. Lyxonic acid (5TMS) 25.90 292
29. Shikimic acid (4TMS) 26.25 204
30. Carbohydrate 26.30 217
31. Citric acid (4TMS)a 26.43 273
32. Carbohydrate (5TMS) 26.50 204
33. Glucopyranoside (5TMS) 26.64 204
34. Pinitol (5TMS)a 26.76 217
35. Quinic acid (5TMS)a 27.24 345
36. Fructose (1MeOx) (5TMS)a 27.60 307
37. Hexose (5TMS) 27.78 191
38. Glucose (1MeOx) (5TMS)a 27.91 319
39. Mannitol (6TMS)a 28.43 319
40. Unknown (inositol isomer) 28.82 305
41. Glucopyranoside (5TMS) 29.27 217
42. Carbohydrate (glucopyranoside 5TMS) 29.28 204
43. Gluconic acid (6TMS) 29.59 333
44. Unknown 6 30.04 204
45. Myo-inositola (6TMS) 30.89 305
46. Sucrose (8TMS)a 38.61 361
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Mass analyzer was used in full scan mode scanning a
range from m/z 40–800 at a scan time of 250 ms. Electron
impact (EI) ionization was used at 70 eV and ion source
temperature was set to 250 C.
Metabolite derivatives were identified by matching reten-
tion time as well as mass spectra (see Table 1) with those of
the corresponding reference standards and by comparison
with an in house mass spectral library. Metabolites were
considered identified with a spectral match factor higher than
850 and RI-deviation lower than 10. Deconvolution was
performed with AMDIS (Stein 1999) and quantification with
LC-Quan2.6.0 (Thermo Fisher Scientific Inc.). For statistical
analyses a Matlab tool called COVAIN was used that provides
a complete workflow including uploading data, data prepro-
cessing, data integration and uni- and multivariate statistical
analysis (Sun and Weckwerth 2012).
2.4 NanoLC-Orbitrap-MS/MS analyses
For all the samples described in the plant material section,
0.12 lg lL-1 water/acetonitrile (95:5, v:v) 0.1 % formic
acid solutions were prepared and centrifuged at
13,0009g for 3 min. For each of them, 5 lL were used for
LC-MS and MS/MS analysis in triplicates.
A 1D plus nanoUHPLC system (Eksigent, Dublin,
Ireland) was equipped with an autosampler and the employed
column was a Waters nanoAcquityHSS T3, 1.8 lm,
100 lm 9 100 mm. The mobile phases were water 0.1 %
formic acid (A) and 90 % acetonitrile in water 0.1 % formic
acid (B) at a flow rate of 500 lL min-1. The LC conditions
were 5 % B during 0–3 min, a linear increase from 5 to 20 %
B during 3–25 min, from 20 to 40 % B during 25–40 min
and from 40 to 50 % B during 40–55 min, finally from 50 to
95 % B during 55–63 min followed by 15 min of mainte-
nance. A Thermo Electron LTQ-Orbitrap XL mass spec-
trometer equipped with a nano electrospray ion source
(ThermoFisher Scientific, Bremen, Germany) and operated
under Xcalibur 2.1 version software, was used in positive
ionization mode for the MS analysis using data-dependent
automatic switching between MS and MS/MS acquisition
modes. The instrument was calibrated using the manufac-
turer’s calibration standards. The scan was collected in the
Orbitrap at a resolution of 30, 000 in a m/z range of
150–1,800. In order to achieve even higher mass accuracy a
lock mass option was enabled in both MS and MS/MS mode
and the cyclomethicone N5 ions generated in the electrospray
process from ambient air (m/z = 371.101230) were used for
internal recalibration in real time. This allowed mass accu-
racies of \1 ppm. The capillary voltage was 4.5 kV, the
tube lens offset 160 V and the capillary temperature was set
at 180 C, no sheath gas and auxiliary gas were used.
Data deconvolution was performed with a modified
ProtMAX version called MetMAX Beta 1.0 which provides
mass accuracy precursor alignment of selected m/z signals
in the LC-MS profile (Hoehenwarter et al. 2008). As for
GC-MS, the COVAIN tool (Sun and Weckwerth 2012) was
used for statistical analyses of the LC-MS data as well.
2.5 MetMAX Beta 1.0 processing and COVAIN
analysis of LC-MS data
Raw data files were converted to mzXml format using the
MassMatrix mass spectrometric data file conversion tool
version 3.9 from the Case Western Reserve University
(Cleveland, Ohio, USA; http://www.massmatrix.net/).
MetMAX Beta 1.0 was used to process the mzXml files,
generating a matrix of precursor ion intensities (Hoe-
henwarter et al. 2008). Each column vector contains the
quantities of selected metabolites; each row vector
describes the abundance of a respective metabolite ion over
the entire set of analyses. Each column was normalized to
its total spectral count. The .csv data table resulting from
MetMAX Beta 1.0 were imported into COVAIN for sta-
tistical analysis (Sun and Weckwerth 2012). The values
were then log-transformed. Principal component analysis
(PCA) was performed for decomposition and visualization
of data. The components of the column vectors, i.e. the
precursor m/z, constitute the loadings of the independent
components, and were identified by matching their reten-
tion times and mass spectra with those of the corresponding
reference standards (see supplementary data).
3 Results and discussion
3.1 Qualitative and quantitative nanoLC-Orbitrap-MS/MS
analyses of P.anserina crude extract
In order to obtain a metabolite profile of the crude
extract of P. anserina, an analytical method based on
Table 1 continued
Compounds Rt (min) Fragments
m/z
47. Trehalose (8TMS)a 39.83 361
48. Isomaltose (1MeOx) (8TMS) 40.89 361
49. Melibiose (1MeOx) (8TMS) 41.16 204
50. Unknown 7 41.77 369
51. Unknown 8 44.22 204
52. Unknown 9 44.35 647
53. Unknown 10 45.38 575
Given are (methoxime)-trimethylsilyl [(MeOx) (TMS)] derivatives of
metabolites including their retention time (Rt) and EI-fragments taken
for relative quantification
a Confirmed by comparison with corresponding reference standard
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nanoLC-Orbitrap-MS/MS was developed. The LC-MS
profile highlighted the presence of a large group of com-
pounds corresponding to the protonated molecular ions of
different flavonoids and caffeoylquinic acids (Fig. 2).
Individual components were identified by comparison of
their m/z values in the Total Ion Count (TIC) profile with
those of the selected compounds described in literature
(Table 2) or by matching their MS/MS spectra with those
Fig. 2 NanoLC-Orbitrap-MS profile (full MS-mode) of the crude hydroalcoholic extract of P. anserina (positive ion mode) (see also Table 2)
Table 2 Retention time (Rt), precursor ions and product ions (for qualitative confirmation of the compound), of compounds occurring in





Product ions (m/z) References
1. Chlorogenic acidb 19.6 377.0477 355; 163 –
2. Chlorogenic acid isomer 25.6 377.0477 355; 163 –
3. Myricetin 3-O-glucuronidea 30.6 495.0769 319 Kombal and Glasl (1995)
4. Quercetin -3-O-sambubiosidea 31.5 597.1451 465; 303 Kombal and Glasl (1995)
5. Myricetin 3-O-rhamnosideb 33.5 465.1025 319 Kombal and Glasl (1995)
6. Quercetin 3-O-glucosideb 34.0 465.1027 303 Kim et al. (2004)
7. Quercetin 3-O-glucuronideb 34.4 479.0817 303 Merfort and Wendisch (1988)
8. Quercetin 3-O-xylosidea 35.3 435.0920 303 Zou et al. (2002)
9. Quercetin pentoside 36.6 435.0921 303 –
10. Kaempferol 3-O-glucosideb 36.8 449.1077 287 Kim et al. (2004)
11. Rutin (mass bank match) 37.1 611.1815 465; 303 Wang et al. (1999)
12. Isorhamnetin3-O-glucuronidea 37.7 493.0975 317 Kombal and Glasl (1995)
13. Acacetin-7-O-rutinoside (mass bank match) 41.7 593.1863 447; 285 –
14. Kaempferol 3-O-rutinoside (mass bank match) 43.6 595.1445 449; 287 –
15. Unknown 45.0 668.4370 489; 471; 453;435; 409 –
16. Unknown 45.7 668.4371 489; 471; 453;407; 316 –
17. Genisteinb 47.0 271.0601 253; 243; 225;215; 197; 159; 153; 145 –
In italised names are putative identifications of compounds, without any comparison with the corresponding reference standard or with Mass
Bank
a Compounds, without any comparison with the corresponding reference standard or with Mass Bank but already reported in P. anserina
b Confirmed by comparison with corresponding reference standard
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reported in a public repository of mass spectral data called
Mass Bank (Horai et al. 2010). According to our knowl-
edge compounds 1, 2, 13, 14, 15, 16, 17 were never
reported in this species. The positive HR-ESI-MS spectrum
of compound 1 showed a [M ? Na]? ion peak at m/z
377.0477 along with a less intense signal at m/z 355 cor-
responding to the protonated ion. The analysis of the MS/
MS spectrum of the sodium adduct of compound 1, high-
lighted the presence of product [(M-192) ? H]? at m/z 163
a.m.u. due to the loss of a quinic acid unit. By comparing
the Rt, the mass and the MS/MS spectra of compound 1
with that of the commercial reference standard we unam-
biguously confirmed chlorogenic acid in P. anserina
extracts (Table 2; Fig. 2).
The analysis of the HR-ESI-MS spectrum of compound
2 suggested it as a chlorogenic acid isomer showing the
diagnostic [M ? Na]? ion at m/z 377.0477 along with the
[M ? H]? ion at m/z 355 with a shift of 6 min in Rt. In
particular, by the analysis of the tandem mass spectrum of
the [M ? H]? ion, compound 2 showed product ions
accounting for the same composition of chlorogenic acid,
originated by the neutral loss of 192 a.m.u. (Table 2;
Fig. 2).
Full positive HR-ESI-MS profile of compound 13 was in
agreement with a di-glycosylated acacetin structure,
showing the diagnostic [M ? H]? ion at m/z 593.1864.
The analysis of the ESI-MS2 spectrum of 13 allowed to
determine the presence of a deoxy-hexose unit, besides
product ion originated by the sequential neutral losses of
146 a.m.u leading to [(M-146) ? H]?ion at m/z 447 and of
162 a.m.u. leading to [(M-146-162) ? H]? ion at m/z 285
corresponding to the acacetin-aglycone (Table 2; Fig. 2).
For identification, the MS2 spectrum of compound 13 was
compared to that of acacetin 7-O-rutinoside present in
Mass Bank library.
The HR-ESI-MS spectrum of compound 14 assigned it
to a diglycosylated kaempferol according to the presence of
the [M ? H]? ion at m/z 595.1445. The tandem mass
experiment on the [M ? H]? ion allowed to observe a
product ion at m/z 449, due to the neutral loss of one
deoxy-hexose 146 a.m.u. and a product ion at m/z 287, due
to the neutral loss of one hexose unit and corresponding to
a kaempferol-aglycon (Table 2; Fig. 2). Identification of
compound 14 as kaempferol 3-O-rutinoside was done by
matching its tandem mass spectra with that of Mass Bank
(data not shown).
According to the HPLC-ESIMS data, the positive
ESIMS spectrum of compound 17 showed a minor
[M ? H]? ion peak at m/z 271.0601. Interestingly, the MS/
MS spectrum of the [M ? H]? ion showed a fragmentation
pattern very similar to what was proposed by Lee et al.
(2002) for the isoflavone genistein. By comparing com-
pound 17 Rt and MS/MS spectra to that of the
corresponding commercial standard we confirmed it as
genistein (Table 2; Fig. 2). Although the presence of gen-
istein and its glycosides is already reported in the family of
Rosaceae (Jung et al. 2002; Lee et al. 2002; Ismail and
Hayes 2005; Tohno et al. 2010) and in Potentilla genus
(S¸o¨hretog˘lu and Sterner 2011), this is the first time that this
isoflavone is reported in this particular species.
For compounds 15 and 16 no unambiguous identifica-
tion was possible. These compounds could be isorhamnetin
derivatives with two glucuronide units according to their
fragmentation pattern in MS/MS. The structural elucidation
is planned in future studies.
3.2 Multivariate statistical analysis of Potentilla
anserina crude and commercial extracts
from different pharmacies
In order to carry out a comparative study between our
P. anserina reference extract and five hydroalcoholic
extracts from different pharmacy vendors all were analyzed
with the same GC- and LC-MS conditions.
In both cases, our results revealed that qualitative pro-
files of mother tinctures seem to be very similar to that of
the crude extract shown in supplementary Fig. 1 and 2.
To better highlight the differences in metabolite profil-
ing of the different extracts of P. anserina, unsupervised
PCA was performed using COVAIN (Sun and Weckwerth
2012). Pre-processed GC-MS data sets (see ‘‘Materials and
methods’’) from the different samples were analyzed. The
PCA scores plot, shown in Fig. 3a, could be readily
divided into two different groups indicating that the content
and distribution of components were different between the
P. anserina crude extracts (PanserinaUniSA and Panseri-
naUnivie) and the respective commercial products. The
corresponding PCA loadings were utilized to identify
the differential metabolic compositions accountable for the
separation among groups (supplementary Fig. 3 and 4 and
supplementary Table 1). In the loadings plot, the Rt and
m/z values which point far away from zero represent
characteristic markers with most confidence to each group.
Unknown 1 (Rt 11.36 min, m/z 133), proline (2TMS)
(Rt 15.59 min, m/z 142), 2-desoxy-pentos-3ylose-dime-
thoxyamine (2TMS) (Rt 25.30 min, m/z 231), carbohy-
drate (Rt 26.30 min, m/z 217), glucopyranoside (5TMS)
(Rt 26.64 min, m/z 204) and unknown 7 (Rt 41.77 min,
m/z 369) (Table 1) accounted primarily for the differences
among our samples.
The nanoLC-Orbitrap-MS/MS data of all determined
samples were processed and aligned with MetMAX Beta
1.0 software by selecting a target list containing all the 17
identified ions (Table 2). The resulting data matrix con-
taining normalized intensities of the selected peaks was
further exported into COVAIN for PCA (Fig. 3b). In this
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latter case chlorogenic acid (Rt 19.6 min, m/z 377.0477),
myricetin-3-O-glucuronide (Rt 30.6 min, m/z 495.0769),
acacetin-7-O-rutinoside (Rt 41.7 min, m/z 593.1863) and
genistein (Rt 47.0 min, m/z 271.0601) (Table 2) are
responsible for the differences among our samples. Both
GC and LC-MS PCA plots showed the same tendencies
between crude extracts and commercial samples (see Figs. 3,
4). In particular it is observed that ‘‘PanserinaUniSa’’ and
‘‘PanserinaUnivie’’ can be considered to be very similar and
also very close to hydroalcoholic extract ‘‘#2’’. As shown in
Fig. 3, extracts # 1, 3, 4 and 5 are far away from the other
three samples.
Fig. 3 a Sample patterns of the hydroalcoholic extracts of
P. anserina analyzed by GC-MS. PC1 occupies 42 % and PC2
23 % of total variance. b Scores plot of the hydroalcoholic extracts of
P. anserina analyzed by LC-MS (only identified compounds used as
variables). PC1 occupies 39 % and PC2 19 % of total variance.
c Sample patterns of the hydroalcoholic extracts of P. anserina
analyzed by LC-MS (all the compounds with RSD \25 used as









































Fig. 4 Sample patterns of
combined GC-MS and LC-MS
data of the hydroalcoholic
extracts of P. anserina
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To obtain a more comprehensive view of the LC-MS
data a second PCA was applied to a dataset pre-processed
by MetMAX Beta 1.0. After calculating the intensity mean,
standard deviation and the relative standard deviation
(RSD) among three technical replicates for all the peaks,
the RSD mean was estimated for each peak and only those
with a value \25 were selected for multivariate statistical
analysis. By application of this method we selected 1,866
variables for PCA (Fig. 3c). Both plots, Fig. 3b and c, are
very similar indicating the robustness of the LC-MS Met-
MAX Beta 1.0 approach.
Eventually the integration of GC-MS and LC-MS data
into one data matrix for PCA showed the clear separation of
the hydroalcoholic extracts PanserinaUniSa, Panserina-
UniVie and #2 from the other extracts (Fig. 4). The loadings
(supplementary Table 1) of this PCA plot demonstrates the
different importance of either GC-MS or LC-MS com-
pounds for sample classification. Synergistic effects of data
integration for sample pattern recognition were also
recently revealed in studies for the integration of primary
and secondary metabolism as well as due to the integration
of metabolomic and proteomic data (Morgenthal et al.
2005; Wienkoop et al. 2008; Doerfler et al. 2012). The
integration of GC-MS and LC-MS data enables the search
of precursor-product correlations in biosynthetic pathways.
This was recently shown in the study by Doerfler et al.
(2012) using Granger causality analysis to reveal the bio-
synthetic interface of primary and secondary metabolism.
3.3 Comparative analysis of genistein in extracts
from different pharmacy vendors
Figure 5 shows the relative evaluation of genistein in all
samples. The values were obtained after normalizing the
LC-MS intensities of this compound against the total
counts of all variables within a sample (calculated with
MetMAX Beta 1.0). The results show the higher amount of
this isoflavone in the extracts of PanserinaUniSa and
PanserinaUniVie as well as in the commercial product 2,
thus confirming the similarities between these three sam-
ples already deduced from PCA analysis. Since genistein is
considered as an active compound in estrogenic therapy
(Ferrante et al. 2004; Hellstrom and Muntzing 2012), our
results highlight that genistein intake may change
depending on the origin of different commercial products,
thereby having different effects on the treatment of PMS.
4 Conclusion
In this study we report for the first time a high resolution
LC-MS method for the evaluation of the chemical compo-
sition of P. anserina polar extracts. By this accurate and
sensitive analysis we revealed the presence of compounds
never reported for P. anserina. Especially important is the
identification of the isoflavone genistein which is considered
as an active compound in the estrogenic therapy. This fact
may explain the positive effect of P. anserina polar extracts
in the treatment of premenstrual syndrome diseases.
Moreover our results showed the advantages of applying
an integrated LC-MS, GC-MS metabolomics platform for
the evaluation of the similarities between medicinal plant
extracts and their commercial products. The unbiased
assignment of m/z features to sample classification using
Mass Accuracy Precursor Alignment (MAPA) and the
corresponding MetMAX algorithm in combination with
multivariate statistics [MAPA and COVAIN; (Hoehenw-
arter et al. 2008; Sun and Weckwerth 2012)] opens up
opportunities to identify novel compounds in the medicinal
plant extracts which were previously not detected. We have
discussed two of these unknowns and will address these
investigations in more detail in future studies.
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